Abstract
Although in-stent restenosis (ISR) occurs after drug-eluting stents (DES) implantation, neointimal tissue characteristics have not been fully investigated. We assessed neointimal tissue components using integrated backscatter intravascular ultrasound (IB-IVUS) after DES and bare-metal stents (BMS) implantation. Fifty-seven consecutive patients with 61 lesions underwent repeated percutaneous coronary intervention (PCI) for the treatment of ISR (DES: 24 lesions, BMS: 37 lesions). PCI was performed using plain old balloon angioplasty (POBA). Before PCI, we assessed neointimal tissue characteristics using IB-IVUS. Neointima was divided into four categories: category 1 (−11 to −29 dB), category 2 (−29 to −35 dB), category 3 (−35 to −49 dB), and category 4 (−49 to −130 dB) according to IB values. We compared neointimal tissue components between DES and BMS. Thirty-three patients with 33 lesions (DES: 17, BMS: 16) were finally included. Neointima was predominantly composed of category 3 tissue in both groups (DES: 68 ± 8%, BMS: 73 ± 5%, P = 0.053). DES had a broader distribution of category 4 tissue component than BMS. After POBA, distal slow flow phenomenon occurred in 5 of DES (29%), whereas none of BMS. In DES, the optimal threshold of category 4 tissue to predict distal slow flow phenomenon after POBA was 30% (sensitivity: 100%, specificity: 92%). Neointima was mainly composed of category 3 tissue at ISR site, irrespective of DES or BMS. In DES, there was a subgroup with category 4 rich tissue, which caused distal slow flow phenomenon after POBA. IB-IVUS might be useful to identify vulnerable neointima in DES restenosis.
Similar content being viewed by others
References
Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF et al (1996) Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94(6):1247–1254
Mehran R, Mintz GS, Hong MK, Tio FO, Bramwell O, Brahimi A et al (1998) Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. J Am Coll Cardiol 32(3):794–799
Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM (2000) Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 35(1):157–163
Murata T, Hiro T, Fujii T, Yasumoto K, Murashige A, Kohno M et al (2002) Impact of the cross-sectional geometry of the post-deployment coronary stent on in-stent neointimal hyperplasia: an intravascular ultrasound study. Circ J 66(5):489–493
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346(23):1773–1780
Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350(3):221–231
Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W et al (2007) Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 100(4):627–630
Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I (2006) Images in cardiovascular medicine. Damage to polymer of a sirolimus-eluting stent. Circulation 114(20):e586–e587
Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109(6):701–705
Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A et al (2002) Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 106(21):2649–2651
Kwon SW, Kim BK, Kim TH, Kim JS, Ko YG, Choi D et al (2011) Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound. Am Heart J 161(2):367–372
Okubo M, Kawasaki M, Ishihara Y, Takeyama U, Kubota T, Yamaki T et al (2008) Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. Ultrasound Med Biol 34(4):655–663
Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K et al (2002) In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 105(21):2487–2492
Okubo M, Kawasaki M, Ishihara Y, Takeyama U, Yasuda S, Kubota T et al (2008) Tissue characterization of coronary plaques: comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasound. Circ J 72(10):1631–1639
Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878
Chieffo A, Foglieni C, Nodari RL, Briguori C, Sangiorgi G, Latib A et al (2009) Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol 104(12):1660–1667
Oikawa Y, Yajima J, Costa MA, Matsuno S, Akabane M, Funada R et al (2010) Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential “thromborestenosis” phenomenon. EuroIntervention 6(3):380–387
van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA et al (2007) Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 28(8):974–979
Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A et al (2006) Intravascular ultrasound characterization of the “black hole” phenomenon after drug-eluting stent implantation. Am J Cardiol 97(2):203–206
Goto K, Shiode N, Shirota K, Fukuda Y, Kitamura F, Tominaga K et al (2009) Pathological finding of sirolimus-eluting stent (SES) restenosis lesion with black hole appearance on intravascular ultrasound. Circ J 73(10):1969–1971
Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW et al (2010) Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol 106(11):1561–1565
Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ et al (2011) Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 123(25):2954–2963
Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y et al (2010) Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 55(1):26–32
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muraoka, Y., Sonoda, S., Kashiyama, K. et al. Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents. Int J Cardiovasc Imaging 28, 1635–1641 (2012). https://doi.org/10.1007/s10554-011-9997-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-011-9997-9